The virus-encoded chemokine vMIP-II inhibits virus-induced Tc1-driven inflammation
about
Kaposi sarcoma-associated herpes virus targets the lymphotactin receptor with both a broad spectrum antagonist vCCL2 and a highly selective and potent agonist vCCL3CCR5 and CXCR3 are dispensable for liver infiltration, but CCR5 protects against virus-induced T-cell-mediated hepatic steatosis.Tumor immune escape by the loss of homeostatic chemokine expression.Lymphocytic choriomeningitis virus-induced central nervous system disease: a model for studying the role of chemokines in regulating the acute antiviral CD8+ T-cell response in an immune-privileged organKaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes.Chemokines encoded by herpesviruses.Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing.Role of macrophage inflammatory protein-1alpha in T-cell-mediated immunity to viral infection.The herpesvirus 8 encoded chemokines vCCL2 (vMIP-II) and vCCL3 (vMIP-III) target the human but not the murine lymphotactin receptor.Eukaryotic expression of the broad-spectrum chemokine receptor antagonist vMIP-II and its effects on T-cell function in vitro and in vivo.Eotaxin-3/CCL26 is a natural antagonist for CC chemokine receptors 1 and 5. A human chemokine with a regulatory role.
P2860
Q28296088-9529763A-ECBF-4EB5-AA8A-AAEF6EBAF4B8Q36098944-0D15BC3F-4BA7-4660-9E61-786E991B1357Q36277205-E0874E85-07FC-43BD-AD3B-E4F73A5F1C26Q37267001-F662AD12-CBBB-4858-A24D-E304863017AEQ38943741-A77B5A58-1588-4337-B2EA-8B28FA1C62BFQ39411850-3D576FB4-AC12-4027-9599-32FCA4451729Q40067378-F847D7EB-EDB1-4AD8-8181-6078F705F352Q40128647-4389CA08-EA33-46C0-B4EB-899831294C15Q40133015-64B83834-856D-4B88-80FE-CE823313B7AEQ42164450-F811C1BD-7D9A-48C8-B99B-F92F8A54218BQ42498236-98D0779E-97F4-4B7F-B2F4-A594D486E281Q47897154-3D2D9D79-61DA-4728-9607-1C6E808BD8F0
P2860
The virus-encoded chemokine vMIP-II inhibits virus-induced Tc1-driven inflammation
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The virus-encoded chemokine vMIP-II inhibits virus-induced Tc1-driven inflammation
@ast
The virus-encoded chemokine vMIP-II inhibits virus-induced Tc1-driven inflammation
@en
type
label
The virus-encoded chemokine vMIP-II inhibits virus-induced Tc1-driven inflammation
@ast
The virus-encoded chemokine vMIP-II inhibits virus-induced Tc1-driven inflammation
@en
prefLabel
The virus-encoded chemokine vMIP-II inhibits virus-induced Tc1-driven inflammation
@ast
The virus-encoded chemokine vMIP-II inhibits virus-induced Tc1-driven inflammation
@en
P2093
P2860
P50
P1433
P1476
The virus-encoded chemokine vMIP-II inhibits virus-induced Tc1-driven inflammation
@en
P2093
Anneline Nansen
Annette Stryhn
Christina Bartholdy
Morten Lindow
Nils J V Hansen
Thomas P Boesen
P2860
P304
P356
10.1128/JVI.77.13.7393-7400.2003
P407
P577
2003-07-01T00:00:00Z